Research Article

Investigation of the protective effect of rosmarinic acid in rats given high dose gentamicin

Volume: 16 Number: 3 July 1, 2023
EN TR

Investigation of the protective effect of rosmarinic acid in rats given high dose gentamicin

Abstract

Purpose: Gentamicin is an antibiotic, used to treat infections caused by microorganisms. Endogenous antioxidants are strengthened by using antioxidant protectors against the toxic effects caused by drugs. Rosmarinic acid has antioxidative, anti-inflammatory, antiapoptotic, and antitumoral effects. In our study, we aimed to investigate the protective effect, immunohistochemical changes, oxidative markers, histopathological changes and inflammation related Ifi44 expression of rosmarinic acid against gentamicin induced nephrotoxicity in rats. Materials and methods: In our study, 32 rats randomly divided into four groups. These groups are consisted of control group, gentamicin group received gentamicin 100 mg/kg/day, gentamicin + rosmarinic group acid received gentamicin 100 mg/kg/day and rosmarinic acid 50 mg/kg/day, and rosmarinic acid group received rosmarinic acid 50 mg/kg/day. At the end of the study, histopathological, immunohistochemical, and biochemical changes in kidney tissues evaluated. Results: Rosmarinic acid reduced creatine, urea, blood urea nitrogen, and total oxidative stress in blood serum. The toxic effect of gentamicin caused severe histopathological changes in the kidneys. A slight decrease in histopathological changes observed in the gentamicin + rosmarinic acid group. Antiproliferative Ifi44 expression was higher in the gentamicin group and gentamicin + rosmarinic acid group. Conclusion: As a result of the application of rosmarinic acid, a decrease in oxygen radicals and an increase in antioxidant levels observed. When used in combination with gentamicin and rosmarinic acid, the protective effect of rosmarinic acid was partially observed, but it could not provide full protection.

Keywords

Project Number

2019SABE014

References

  1. 1. Ali BH, AI Za’abi M, Blunden G, Nemmar A. Experimental gentamicin nephrotoxicity and agents that modify it: a mini-review of recent research. Basic Clin Pharmacol Toxicol 2011;109:225-232. https://doi. org/10.1111/j.1742-7843.2011.00728.x
  2. 2. Lenoir M, Marot M, Uziel A. Comparative ototoxicity of four aminoglycosidic antibiotics during the critical period of cochlear development in the rat. A functional and structural study. Acta Otolaryngol Suppl 1983;405:1- 16. https://doi.org/ 10.3109/00016488309105593
  3. 3. Vera Roman J, Krishnakantha TP, Cuppage FE. Gentamicin nephrotoxicitiy in rats. I. Acute biochemical and ultrastructural effects. Lab İnvest 1975;33:412- 417.
  4. 4. Geleilete TJ, Melo GC, Costa RS, Volpini RA, Soares TJ, Coimbra TM. Role of myofibroblasts, macrophages, transforming growth factor-beta endothelin, angiotensin-ll, and fibronectin in the progression of tubulointerstitial nephritis induced by gentamicin. J Nephrol 2002;15:633-642.
  5. 5. Yaman O, Balikci E. Protective effects of nigella sativa against gentamicin-induced nephrotoxicitiy in rats. ExpToxicol Pathol 2009;62:183-90. https://doi. org/10.1016/j.etp.2009.03.006
  6. 6. Lee KE, Kim EY, Kim CS, et al. Macrophage stimulating protein attenuates gentamicin-induced iniammation and apoptosis in human renal proximal tubular epithelial cells. Biochem Biophys Res Commun 2013;434:527- 533. https://doi.org/10.1016/j.bbrc.2013.03.108
  7. 7. Monteiro HS, Silva JA, Vieira PC, et al. Gingerol fraction from Zingiber officinale protects against gentamicin-induced nephrotoxicity. Antimicrob Agents Chemother 2014;58:1872-1878. http://doi.org/10.1128/ AAC.02431-13
  8. 8. Brewer MS. Natural antioxidants: sources, compounds, mechanisms of action, and potential applications. Compr Rev Food Sci Food Saf 2011;10:221-247. https://doi.org/10.1111/j.1541-4337.2011.00156.x

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Early Pub Date

June 14, 2023

Publication Date

July 1, 2023

Submission Date

March 20, 2023

Acceptance Date

June 12, 2023

Published in Issue

Year 2023 Volume: 16 Number: 3

APA
Çetin, H., Gündüz, D., & Aybek, H. (2023). Investigation of the protective effect of rosmarinic acid in rats given high dose gentamicin. Pamukkale Medical Journal, 16(3), 486-497. https://doi.org/10.31362/patd.1268311
AMA
1.Çetin H, Gündüz D, Aybek H. Investigation of the protective effect of rosmarinic acid in rats given high dose gentamicin. Pam Med J. 2023;16(3):486-497. doi:10.31362/patd.1268311
Chicago
Çetin, Hülya, Damla Gündüz, and Hülya Aybek. 2023. “Investigation of the Protective Effect of Rosmarinic Acid in Rats Given High Dose Gentamicin”. Pamukkale Medical Journal 16 (3): 486-97. https://doi.org/10.31362/patd.1268311.
EndNote
Çetin H, Gündüz D, Aybek H (July 1, 2023) Investigation of the protective effect of rosmarinic acid in rats given high dose gentamicin. Pamukkale Medical Journal 16 3 486–497.
IEEE
[1]H. Çetin, D. Gündüz, and H. Aybek, “Investigation of the protective effect of rosmarinic acid in rats given high dose gentamicin”, Pam Med J, vol. 16, no. 3, pp. 486–497, July 2023, doi: 10.31362/patd.1268311.
ISNAD
Çetin, Hülya - Gündüz, Damla - Aybek, Hülya. “Investigation of the Protective Effect of Rosmarinic Acid in Rats Given High Dose Gentamicin”. Pamukkale Medical Journal 16/3 (July 1, 2023): 486-497. https://doi.org/10.31362/patd.1268311.
JAMA
1.Çetin H, Gündüz D, Aybek H. Investigation of the protective effect of rosmarinic acid in rats given high dose gentamicin. Pam Med J. 2023;16:486–497.
MLA
Çetin, Hülya, et al. “Investigation of the Protective Effect of Rosmarinic Acid in Rats Given High Dose Gentamicin”. Pamukkale Medical Journal, vol. 16, no. 3, July 2023, pp. 486-97, doi:10.31362/patd.1268311.
Vancouver
1.Hülya Çetin, Damla Gündüz, Hülya Aybek. Investigation of the protective effect of rosmarinic acid in rats given high dose gentamicin. Pam Med J. 2023 Jul. 1;16(3):486-97. doi:10.31362/patd.1268311

Creative Commons Lisansı

Pamukkale Medical Journal is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC).